Canagliflozin - Johnson & Johnson/Mitsubishi Tanabe Pharma Corporation
At a glance
- Drug Originator Tanabe Seiyaku
- Drug Licenced by CSL Vifor; Daiichi Sankyo Company; Johnson & Johnson; Merck KGaA; Mundipharma Medical Company; Tai Tien Pharmaceuticals
- Drug Class Antihyperglycaemics; Cardiovascular therapies; Glucosides; Heart failure therapies; Obesity therapies; Small molecules; Thiophenes
- Mechanism of Action Sodium-glucose transporter 2 inhibitors
- USA Patent Applicants JANSSEN PHARMS
- USA Patents 21
- NDAs 1
- International Patents 270
- Patent Applications 512
Table of Contents
Disclaimer